Total Payments
$56,393
2024 Payments
$5,542
Companies
84
Transactions
2,365
Medicare Patients
6,733
Medicare Billing
$461,304
Payment Breakdown by Category
Food & Beverage$48,702 (86.4%)
Gifts$2,774 (4.9%)
Other$1,763 (3.1%)
Education$1,654 (2.9%)
Consulting$1,500 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $48,702 | 2,279 | 86.4% |
| Gift | $2,774 | 26 | 4.9% |
| Long term medical supply or device loan | $1,763 | 19 | 3.1% |
| Education | $1,654 | 40 | 2.9% |
| Consulting Fee | $1,500 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $8,667 | 184 | $0 (2024) |
| Gilead Sciences, Inc. | $5,025 | 173 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,119 | 183 | $0 (2024) |
| Amgen Inc. | $3,071 | 118 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,846 | 111 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,757 | 150 | $0 (2023) |
| Merck Sharp & Dohme LLC | $2,638 | 136 | $0 (2024) |
| PFIZER INC. | $2,289 | 141 | $0 (2024) |
| Lilly USA, LLC | $1,737 | 110 | $0 (2024) |
| Janssen Biotech, Inc. | $1,598 | 72 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,542 | 232 | Gilead Sciences, Inc. ($679.80) |
| 2023 | $5,913 | 244 | Novartis Pharmaceuticals Corporation ($662.22) |
| 2022 | $5,883 | 281 | Gilead Sciences, Inc. ($598.20) |
| 2021 | $7,052 | 291 | Novartis Pharmaceuticals Corporation ($1,281) |
| 2020 | $5,389 | 246 | Novartis Pharmaceuticals Corporation ($742.45) |
| 2019 | $7,771 | 360 | Novartis Pharmaceuticals Corporation ($1,269) |
| 2018 | $9,670 | 377 | Novartis Pharmaceuticals Corporation ($1,632) |
| 2017 | $9,174 | 334 | Novartis Pharmaceuticals Corporation ($2,082) |
All Payment Transactions
2,365 individual payment records from CMS Open Payments — Page 1 of 95
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.04 | General |
| 12/12/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: VACCINES | ||||||
| 12/09/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: Hematology | ||||||
| 12/07/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.34 | General |
| 12/05/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $18.85 | General |
| Category: Hematology/Oncology | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 11/29/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Bone Health | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $19.28 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Oncology | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.39 | General |
| 11/06/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 734 | 1,282 | $118,943 | $65,733 |
| 2022 | 16 | 809 | 1,329 | $139,139 | $73,047 |
| 2021 | 21 | 3,766 | 6,962 | $401,368 | $207,246 |
| 2020 | 22 | 1,424 | 4,154 | $270,033 | $115,279 |
Total Patients
6,733
Total Services
13,727
Medicare Billing
$461,304
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 19 | 19 | $665.00 | $261.78 | 39.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2021 | 13 | 56 | $46.37 | $31.08 | 67.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 12 | 220 | $70.90 | $25.69 | 36.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 273 | 997 | $141,824 | $57,184 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 82 | 82 | $19,246 | $11,169 | 58.0% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 154 | 270 | $20,980 | $10,204 | 48.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 63 | 86 | $11,659 | $5,746 | 49.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 55 | $10,722 | $5,049 | 47.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 70 | 101 | $8,699 | $4,129 | 47.5% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 113 | 117 | $5,453 | $3,407 | 62.5% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 13 | 13 | $4,502 | $2,952 | 65.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 27 | 27 | $6,173 | $2,646 | 42.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 123 | 126 | $6,275 | $2,439 | 38.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 42 | 56 | $5,243 | $2,244 | 42.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 35 | 35 | $9,752 | $1,694 | 17.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 12 | 12 | $2,279 | $1,407 | 61.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 12 | 20 | $2,931 | $1,320 | 45.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 31 | 79 | $4,245 | $1,022 | 24.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 187 | 293 | $1,973 | $874.68 | 44.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 41 | 55 | $4,565 | $602.48 | 13.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 24 | 24 | $1,175 | $463.08 | 39.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 31 | 35 | $1,472 | $450.15 | 30.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 12 | 12 | $627.56 | $255.88 | 40.8% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2020 | 14 | 39 | $232.99 | $19.33 | 8.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 16 | 1,620 | $0.30 | $0.27 | 90.0% |
About Dr. William Cheung, M.D
Dr. William Cheung, M.D is a Hematology & Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629031208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Cheung, M.D has received a total of $56,393 in payments from pharmaceutical and medical device companies, with $5,542 received in 2024. These payments were reported across 2,365 transactions from 84 companies. The most common payment nature is "Food and Beverage" ($48,702).
As a Medicare-enrolled provider, Cheung has provided services to 6,733 Medicare beneficiaries, totaling 13,727 services with total Medicare billing of $461,304. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location New York, NY
- Active Since 04/06/2006
- Last Updated 02/24/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629031208
Products in Payments
- KISQALI (Drug) $4,757
- OPDIVO (Biological) $2,034
- KEYTRUDA (Biological) $1,809
- PDR001 (Drug) $1,567
- FARXIGA (Drug) $1,141
- JARDIANCE (Drug) $793.00
- GILOTRIF (Drug) $791.33
- TAGRISSO (Drug) $782.14
- Tymlos (Biological) $755.69
- Lenvima (Drug) $734.59
- Vemlidy (Drug) $715.98
- Ozempic (Drug) $686.14
- PRADAXA (Drug) $569.33
- BEVESPI AEROSPHERE (Drug) $550.42
- Doptelet (Drug) $545.17
- IBRANCE (Drug) $541.37
- Creon (Drug) $525.14
- CABOMETYX (Drug) $518.95
- NINLARO (Drug) $508.59
- TRULICITY (Drug) $499.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in New York
Jeffrey Zwicker, M.d, M.D
Hematology & Oncology — Payments: $1.2M
Hematology & Oncology $1.2M
Manuel Hidalgo Medina, M.d, M.D
Hematology & Oncology — Payments: $1.1M
Hematology & Oncology $1.1M
Dr. Ahmed Sawas, M.d, M.D
Hematology & Oncology — Payments: $807,524
Hematology & Oncology $807,524
Ruben Niesvizky, Md, MD
Hematology & Oncology — Payments: $734,512
Hematology & Oncology $734,512
Jeffrey Laurence, Md, MD
Hematology & Oncology — Payments: $706,018
Hematology & Oncology $706,018
Dr. Joshua Sabari, M.d, M.D
Hematology & Oncology — Payments: $603,205
Hematology & Oncology $603,205